Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Heart Failure × Watchful Waiting × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 24 Carcinoma, Non-Small-Cell Lung 13 Breast Neoplasms 13 Neoplasms 9 Colonic Neoplasms 7 Lung Neoplasms 6 Urinary Bladder Neoplasms 5 Uterine Cervical Neoplasms 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Brain Neoplasms 4 Thrombocythemia, Essential 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Polycythemia Vera 3 Papillomavirus Infections 3 Oropharyngeal Neoplasms 3 Neuroblastoma 3 Mouth Neoplasms 3 Liver Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hodgkin Disease 3 Gallbladder Neoplasms 3 Esophageal Neoplasms 3 Anus Neoplasms 3 Vulvar Neoplasms 2 Uterine Cervical Dysplasia 2 Triple Negative Breast Neoplasms 2 Thyroid Nodule 2

Interventions

Echocardiography 4 Standard of Care 3 Exercise 3 Electrocardiography 3 sacubitril and valsartan sodium hydrate drug combination 2 Surveys and Questionnaires 2 Spironolactone 2 Rituximab 2 Nutrition Assessment 2 Lenalidomide 2 Ivabradine 2 Control Groups 2 Carvedilol 2 Blood Specimen Collection 2 Atorvastatin 2 Adrenergic beta-Antagonists 2 ziprasidone 1 pertuzumab 1 pegfilgrastim 1 obinutuzumab 1 nicotinamide-beta-riboside 1 empagliflozin 1 dapagliflozin 1 candesartan 1 acalabrutinib 1 Zolpidem 1 Watchful Waiting 1 Warfarin 1 Vincristine 1 Vecuronium Bromide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05622669 2024-04-05

FATIGUE

University of Aberdeen

Post-Acute COVID-19 Syndrome, Heart Failure, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡